Antimicrobial polymers for antibiofilm medical devices: State-of-Art and perspectives

Advances in Experimental Medicine and Biology

Volumn 831, Issue , 2015, Pages 93-117

  Francolini, Iolanda ^a   Donelli, Gianfranco ^b   Crisante, Fernanda ^a   Taresco, Vincenzo ^a   Piozzi, Antonella ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIMICROBIAL POLYMER; BENZALKONIUM CHLORIDE; CARBON; CHLORHEXIDINE; CLINDAMYCIN; COLISTIN; DISINFECTANT AGENT; ERYTHROMYCIN; GENTAMICIN; HEPARIN; MACROGOL; METAL; MINOCYCLINE; PLATINUM; POLYMER; RIFAMPICIN; SULFADIAZINE SILVER; TOBRAMYCIN; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT;

ARTICLE; BACTERIAL COLONIZATION; BIOFILM; CANDIDA; CATHETER INFECTION; CENTRAL VENOUS CATHETER; FOULING CONTROL; FUNGAL COLONIZATION; HUMAN; MATERIAL COATING; MEDICAL DEVICE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL ADHESION; NONHUMAN; ORTHOPEDIC IMPLANT; PERIPROSTHETIC JOINT INFECTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS EPIDERMIDIS; URINARY CATHETER; URINARY TRACT INFECTION; WOUND DRESSING; CATHETER-RELATED INFECTIONS; CHEMICAL STRUCTURE; CHEMISTRY; DEVICES; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; PROSTHESIS-RELATED INFECTIONS;

ANTI-INFECTIVE AGENTS; BIOFILMS; CATHETER-RELATED INFECTIONS; EQUIPMENT AND SUPPLIES; HUMANS; MOLECULAR STRUCTURE; POLYMERS; PROSTHESIS-RELATED INFECTIONS;

EID: 84926672864     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-09782-4_7     Document Type: Article

References (171)

1. Abdelkefi A, Achour W, Ben OT et al (2007) Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection. J Support Oncol 5: 273-278.
2. Allison BC, Applegate BM, Youngblood JP (2007) Hemocompatibility of hydrophilic antimicrobial copolymers of alkylated 4-vinylpyridine. Biomacromolecules 8: 2995-2999.
3. Alsarra IA (2009) Chitosan topical gel formulation in the management of burn wounds. Int J Biol Macromol 45: 16-21.
4. An YH, Stuart GW, McDowell SJ et al (1996) Prevention of bacterial adherence to implant surfaces with a crosslinked albumin coating in vitro. J Orthop Res 14: 846-849.
5. Anderson EB, Long TE (2010) Imidazole-and imidazolium-containing polymers for biology and material science applications. Polymer 51: 2447-2454.
6. Appelgren P, Ransjo U, Bindslev L et al (1996) Surface heparinization of central venous catheters reduces microbial colonization in vitro and in vivo: results from a prospective, randomized trial. Crit Care Med 24: 1482-1489.
7. Aumsuwan N, Heinhorst S, Urban MW (2007) The effectiveness of antibiotic activity of penicillin attached to expanded poly(tetrafluoroethylene) (ePTFE) surfaces: a quantitative assessment. Biomacromolecules 8: 3525-3530.
8. Aumsuwan N, Danyus RC, Heinhorst S et al (2008) Attachment of ampicillin to expanded poly(tetrafluoroethylene): surface reactions leading to inhibition of microbial growth. Biomacromolecules 9: 1712-1718.
9. Aumsuwan N, McConnell MS, Urban MW (2009) Tunable antimicrobial polypropylene surfaces: simultaneous attachment of penicillin (Gram plus) and gentamicin (Gram-). Biomacromolecules 10: 623-629.
10. Banerjee I, Pangule RC, Kane RS (2011) Antifouling coatings: recent developments in the design of surfaces that prevent Fouling by proteins, bacteria, and marine organisms. Adv Mater 23: 690-718.
11. Bertazzoni ME, Benini A, Samaila E et al (2014) Antimicrobial activity of gentamicin and vancomycin combination in joint fluids after antibiotic-loaded cement spacer implantation in two-stage revision surgery. J Chemother. doi: 10. 1179/1973947813Y. 0000000157.
12. Beven L, Castano S, Dufourcq J et al (2003) The antibiotic activity of cationic linear amphipathic peptides: lessons from the action of leucine/lysine copolymers on bacteria of the class Mollicutes. Eur J Biochem 270: 2207-2217.
13. Biering-Sorensen F (2002) Urinary tract infection in individuals with spinal cord lesion. Curr Opin Urol 12: 45-49.
14. Boateng JS, Matthews KH, Stevens HNE et al (2008) Wound healing dressings and drug delivery systems: a review. J Pharm Sci 97: 2892-2923.
15. Bong JJ, Kite P, Wilco MH et al (2003) Prevention of catheter related bloodstream infection by silver iontophoretic central venous catheters: a randomised controlled trial. J Clin Pathol 56: 731-735.
16. Broomfield RJ, Morgan SD, Khan A et al (2009) Crystalline bacterial biofilm formation on urinary catheters by urease-producing urinary tract pathogens: a simple method of control. J Med Microbiol 58: 1367-1375.
17. Brun-Buisson C, Doyon F, Sollet JP et al (2004) Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial. Intensive Care Med 30: 837-843.
18. Cakmak I, Ulukanli Z, Tuzcu M et al (2004) Synthesis and characterization of novel antimicrobial cationic polyelectrolytes. Eur Polym J 40: 2373-2379.
19. Callow ME, Fletcher RL (1994) The influence of low surface-energy materials on bioadhesion-a review. Int Biodeter Biodegr 34: 333-348.
20. Campoccia D, Montanaro L, Arciola CR (2006) The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials 27: 2331-2339.
21. Casey AL, Mermel LA, Nightingale P et al (2008) Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. Lancet Infect Dis 8: 763-776.
22. Chen CZS, Beck-Tan NC, Dhurjati P et al (2000) Quaternary ammonium functionalized poly(propylene imine) dendrimers as effective antimicrobials: structure-activity studies. Biomacromolecules 1: 473-480.
23. Chen S, Yu F, Yu Q et al (2006) Strong resistance of a thin crystalline layer of balanced charged groups to protein adsorption. Langmuir 22: 8186-8191.
24. Chen SF, Li LY, Zhao C et al (2010) Surface hydration: principles and applications toward low-fouling/nonfouling biomaterials. Polymer 51: 5283-5293.
25. Cheng H, Li Y, Huo K et al (2014) Long-lasting in vivo and in vitro antibacterial ability of nanostructured titania coating incorporated with silver nanoparticles. J Biomed Mater Res A 102(10): 3488-3499.
26. Cho YS, Lee JW, Lee JS et al (2002) Hyaluronic acid and silver sulfadiazine-impregnated polyurethane foams for wound dressing application. J Mater Sci Mater Med 13: 861-865.
27. Cooper HJ, Della Valle CJ (2013) The two-stage standard in revision total hip replacement. Bone Joint J 95-B: 84-87.
28. Corona PS, Barro V, Mendez M et al (2014) Industrially prefabricated cement spacers: do vancomycin-and gentamicin-impregnated spacers offer any advantage? Clin Orthop Relat Res 472: 923-932.
29. Corral L, Nolla-Salas M, Ibanez-Nolla J et al (2003) A prospective, randomized study in critically ill patients using the Oligon Vantex catheter. J Hosp Infect 55: 212-219.
30. Dai T, Tanaka M, Huang YY et al (2011) Chitosan preparations for wounds and burns: antimicrobial and wound-healing effects. Expert Rev Anti Infect Ther 9: 857-879.
31. Dall GF, Simpson PM, Breusch SJ (2007) In vitro comparison of Refobacin-Palacos R with Refobacin Bone Cement and Palacos R + G. Acta Orthop 78: 404-411.
32. Darouiche RO, Smith JA, Hanna H et al (1999) Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial. Urology 54: 976-981.
33. Darouiche RO, Berger DH, Khardori N et al (2005) Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial. Ann Surg 242: 193-200.
34. Davenport K, Keeley FX (2005) Evidence for the use of silver-alloy-coated urethral catheters. J Hosp Infect 60: 298-303.
35. Dizman B, Elasri MO, Mathias LJ (2006) Synthesis and characterization of antibacterial and temperature responsive methacrylamide polymers. Macromolecules 39: 5738-5746.
36. Donelli G, Vuotto C (2014) Biofilm-based infections in longterm care facilities. Future Microbiol 9(2): 175-188.
37. Donelli G, Francolini I, Piozzi A et al (2002) New polymer-antibiotic systems to inhibit bacterial biofilm formation: a suitable approach to prevent central venous catheter-associated infections. J Chemother 14: 501-507.
38. Elsner JJ, Zilberman M (2009) Antibiotic-eluting bioresorbable composite fibers for wound healing applications: microstructure, drug delivery and mechanical properties. Acta Biomater 5: 2872-2883.
39. Elsner JJ, Egozi D, Ullmann Y et al (2011) Novel biodegradable composite wound dressings with controlled release of antibiotics: results in a guinea pig burn model. Burns 37: 896-904.
40. Engesaeter LB, Espehaug B, Lie SA et al (2006) Does cement increase the risk of infection in primary total hip arthroplasty? Revision rates in 56, 275 cemented and uncemented primary THAs followed for 0-16 years in the Norwegian Arthroplasty Register. Acta Orthop 77: 351-358.
41. Ensing GT, van Horn JR, van der Mei HC et al (2008) Copal bone cement is more effective in preventing biofilm formation than Palacos R-G. Clin Orthop Relat Res 466: 1492-1498.
42. Fallon MT, Shafer W, Jacob E (1999) Use of cefazolin microspheres to treat localized methicillin-resistant Staphylococcus aureus infections in rats. J Surg Res 86: 97-102.
43. Fitzpatrick F, Humphreys H, O'Gara JP (2005) The genetics of staphylococcal biofilm formation-will a greater understanding of pathogenesis lead to better management of device-related infection? Clin Microbiol Infect 11: 967-973.
44. Francesko A, Tzanov T (2011) Chitin, chitosan and derivatives for wound healing and tissue engineering. Adv Biochem Eng Biotechnol 125: 1-27.
45. Francesko A, da Soares CD, Reis RL et al (2013) Functional biopolymer-based matrices for modulation of chronic wound enzyme activities. Acta Biomater 9: 5216-5225.
46. Francolini I, Norris P, Piozzi A et al (2004) Usnic acid, a natural antimicrobial agent able to inhibit bacterial biofilm formation on polymer surfaces. Antimicrob Agents Chemother 48: 4360-4365.
47. Francolini I, D'Ilario L, Guaglianone E et al (2010) Polyurethane anionomers containing metal ions with antimicrobial properties: thermal, mechanical and biological characterization. Acta Biomater 6: 3482-3490.
48. Francolini I, Taresco V, Crisante F et al (2013) Water soluble usnic acid-polyacrylamide complexes with enhanced antimicrobial activity against Staphylococcus epidermidis. Int J Mol Sci 14: 7356-7369.
49. Francolini I, Donelli G, Vuotto C et al (2014) Antifouling polyurethanes to fight device-related staphylococcal infections: synthesis, characterization, and antibiofilm efficacy. Pathog Dis 70: 401-407.
50. Gao BJ, Zhang X, Zhu Y (2007) Studies on the preparation and antibacterial properties of quaternized polyethyleneimine. J Biomater Sci Polym Ed 18: 531-544.
51. Garvin KL, Hanssen AD (1995) Infection after total hip arthroplasty. Past, present, and future. J Bone Joint Surg Am 77: 1576-1588.
52. Gilchrist SE, Lange D, Letchford K et al (2013) Fusidic acid and rifampicin co-loaded PLGA nanofibers for the prevention of orthopedic implant associated infections. J Control Release 170: 64-73.
53. Gottenbos B, van der Mei HC, Klatter F et al (2002) In vitro and in vivo antimicrobial activity of covalently coupled quaternary ammonium silane coatings on silicone rubber. Biomaterials 23: 1417-1423.
54. Halevy R, Rozek A, Kolusheva S et al (2003) Membrane binding and permeation by indolicidin analogs studied by a biomimetic lipid/polydiacetylene vesicle assay. Peptides 24: 1753-1761.
55. Hallan G, Aamodt A, Furnes O et al (2006) Palamed G compared with Palacos R with gentamicin in Charnley total hip replacement. A randomised, radiostereometric study of 60 HIPS. J Bone Joint Surg Br 88: 1143-1148.
56. Halton KA, Cook DA, Whitby M et al (2009) Cost effectiveness of antimicrobial catheters in the intensive care unit: addressing uncertainty in the decision. Crit Care 13: R35.
57. Hanna H, Benjamin R, Chatzinikolaou I et al (2004) Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial. J Clin Oncol 22: 3163-3171.
58. Harney MB, Pant RR, Fulmer PA et al (2009) Surface self-concentrating amphiphilic quaternary ammonium biocides as coating additives. ACS Appl Mater Interfaces 1: 39-41.
59. Helander IM, Alakomi HL, LatvaKala K et al (1997) Polyethyleneimine is an effective permeabilizer of Gram-negative bacteria. Microbiology (UK) 143: 3193-3199.
60. Holmberg KV, Abdolhosseini M, Li Y et al (2013) Bioinspired stable antimicrobial peptide coatings for dental applications. Acta Biomater 9: 8224-8231.
61. Ikeda T, Hirayama H, Yamaguchi H et al (1986) Polycationic biocides with pendant active groups-molecular-weight dependence of antibacterial activity. Antimicrob Agents Chemother 30: 132-136.
62. Jain G, Allon M, Saddekni S et al (2009) Does heparin coating improve patency or reduce infection of tunneled dialysis catheters? Clin J Am Soc Nephrol 4: 1787-1790.
63. Jamal MA, Rosenblatt JS, Hachem RY et al (2014) Prevention of biofilm colonization by Gram-negative bacteria on minocycline-rifampin-impregnated catheters sequentially coated with chlorhexidine. Antimicrob Agents Chemother 58: 1179-1182.
64. Jiranek WA, Hanssen AD, Greenwald AS (2006) Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. J Bone Joint Surg Am 88: 2487-2500.
65. Johnson JR, Kuskowski MA, Wilt TJ (2006) Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients. Ann Intern Med 144: 116-126.
66. Johnson JR, Johnston B, Kuskowski MA (2012) In vitro comparison of nitrofurazone-and silver alloy-coated Foley catheters for contact-dependent and diffusible inhibition of urinary tract infection-associated microorganisms. Antimicrob Agents Chemother 56: 4969-4972.
67. Jones BV, Young R, Mahenthiralingam E et al (2004) Ultrastructure of Proteus mirabilis swarmer cell rafts and role of swarming in catheter-associated urinary tract infection. Infect Immun 72: 3941-3950.
68. Jones GL, Russell AD, Caliskan Z et al (2005) A strategy for the control of catheter blockage by crystalline Proteus mirabilis biofilm using the antibacterial agent triclosan. Eur Urol 48: 838-845.
69. Kalfon P, de Vaumas C, Samba D et al (2007) Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients. Crit Care Med 35: 1032-1039.
70. Kalsi J, Arya M, Wilson P et al (2003) Hospital-acquired urinary tract infection. Int J Clin Pract 57: 388-391.
71. Kanazawa A, Ikeda T, Endo T (1994) Synthesis and antimicrobial activity of dimethyl-and trimethylsubstituted phosphonium salts with alkyl chains of various lengths. Antimicrob Agents Chemother 38: 945-952.
72. Kanazawa A, Ikeda T, Endo T (1995) A novel approach to mode of action of cationic biocides: morphological effect on antibacterial activity. J Appl Bacteriol 78: 55-60.
73. Kaplan L, Kurdziel M, Baker KC et al (2012) Characterization of daptomycin-loaded antibiotic cement. Orthopedics 35: e503-e509.
74. Karlsmark T, Agerslev RH, Bendz SH et al (2003) Clinical performance of a new silver dressing, Contreet Foam, for chronic exuding venous leg ulcers. J Wound Care 12: 351-354.
75. Katti DS, Robinson KW, Ko FK et al (2004) Bioresorbable nanofiber-based systems for wound healing and drug delivery: optimization of fabrication parameters. J Biomed Mater Res B Appl Biomater 70B: 286-296.
76. Kaur S, Harjai K, Chhibber S (2014) Bacteriophage mediated killing of Staphylococcus aureus in vitro on orthopaedic K wires in presence of linezolid prevents implant colonization. PLoS One 9: e90411.
77. Kazemzadeh-Narbat M, Lai BF, Ding C et al (2013) Multilayered coating on titanium for controlled release of antimicrobial peptides for the prevention of implantassociated infections. Biomaterials 34: 5969-5977.
78. Kenawy ER, Abdel-Hay FI, Abou El-Magd A et al (2006) Biologically active polymers: VII. Synthesis and antimicrobial activity of some crosslinked copolymers with quaternary ammonium and phosphonium groups. React Funct Polym 66: 419-429.
79. Kenawy E, Worley SD, Broughton R (2007) The chemistry and applications of antimicrobial polymers: a stateof-the-art review. Biomacromolecules 8: 1359-1384.
80. Khalil H, Chen T, Riffon R et al (2008) Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa. Antimicrob Agents Chemother 52: 1635-1641.
81. Klevens RM, Edwards JR, Richards CL Jr et al (2007) Estimating health care-associated infections and deaths in U. S. hospitals, 2002. Public Health Rep 122: 160-166.
82. Kugel A, Chisholm B, Ebert S et al (2010) Antimicrobial polysiloxane polymers and coatings containing pendant levofloxacin. Polym Chem 1: 442-452.
83. Kumar PTS, Abhilash S, Manzoor K et al (2010) Preparation and characterization of novel beta-chitin/nanosilver composite scaffolds for wound dressing applications. Carbohydr Polym 80: 761-767.
84. Kuroda K, Caputo GA, DeGrado WF (2009) The role of hydrophobicity in the antimicrobial and hemolytic activities of polymethacrylate derivatives. Chem Eur J 15: 1123-1133.
85. Kurtz SM, Ong KL, Schmier J et al (2007) Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am 89(Suppl 3): 144-151.
86. Lai NM, Chaiyakunapruk N, Lai NA et al (2013) Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults. Cochrane Database Syst Rev 6: Art. No.: CD007878.
87. Lee YH, Chang JJ, Yang MC et al (2012) Acceleration of wound healing in diabetic rats by layered hydrogel dressing. Carbohydr Polym 88: 809-819.
88. Leon C, Ruiz-Santana S, Rello J et al (2004) Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial. Intensive Care Med 30: 1891-1899.
89. Lewis K, Klibanov AM (2005) Surpassing nature: rational design of sterile-surface materials. Trends Biotechnol 23: 343-348.
90. Li Y, Xiong W, Zhang C et al (2013) Enhanced osseointegration and antibacterial action of zinc-loaded titaniananotube-coated titanium substrates: in vitro and in vivo studies. J Biomed Mater Res A. doi: 10. 1002/jbm. a. 35060.
91. Lin J, Winkelman C, Worley SD et al (2001) Antimicrobial treatment of nylon. J Appl Polym Sci 81: 943-947.
92. Lin J, Winkelmann C, Worley SD et al (2002) Biocidal polyester. J Appl Polym Sci 85: 177-182.
93. Lin WT, Tan HL, Duan ZL et al (2014) Inhibited bacterial biofilm formation and improved osteogenic activity on gentamicin-loaded titania nanotubes with various diameters. Int J Nanomedicine 9: 1215-1230.
94. Lindner E (1992) A low surface free energy approach in the control of marine biofouling. Biofouling 6: 193-205.
95. Liu DH, DeGrado WF (2001) De novo design, synthesis, and characterization of antimicrobial beta-peptides. J Am Chem Soc 123: 7553-7559.
96. Lorente L, Lecuona M, Ramos MJ et al (2008) The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia. Clin Infect Dis 47: 1171-1175.
97. Lu GQ, Wu DC, Fu RW (2007) Studies on the synthesis and antibacterial activities of polymeric quaternary ammonium salts from dimethylaminoethyl methacrylate. React Funct Polym 67: 355-366.
98. Lynch AS, Robertson GT (2008) Bacterial and fungal biofilm infections. Annu Rev Med 59: 415-428.
99. Macleod SM, Stickler DJ (2007) Species interactions in mixed-community crystalline biofilms on urinary catheters. J Med Microbiol 56: 1549-1557.
100. Madhumathi K, Kumar PTS, Abhilash S et al (2010) Development of novel chitin/nanosilver composite scaffolds for wound dressing applications. J Mater Sci Mater Med 21: 807-813.
101. Magnan B, Bondi M, Maluta T et al (2013) Acrylic bone cement: current concept review. Musculoskelet Surg 97: 93-100.
102. Makal U, Wood L, Ohman DE et al (2006) Polyurethane biocidal polymeric surface modifiers. Biomaterials 27: 1316-1326.
103. Masri BA, Duncan CP, Beauchamp CP (1998) Long-term elution of antibiotics from bone-cement: an in vivo study using the prosthesis of antibiotic-loaded acrylic cement (PROSTALAC) system. J Arthroplasty 13: 331-338.
104. Mermel LA (2011) What is the predominant source of intravascular catheter infections? Clin Infect Dis 52: 211-212.
105. Mermel LA, Stolz SM, Maki DG (1993) Surface antimicrobial activity of heparin-bonded and antisepticimpregnated vascular catheters. J Infect Dis 167: 920-924.
106. Mizerska U, Fortuniak W, Chojnowski J et al (2009) Polysiloxane cationic biocides with imidazolium salt (ImS) groups, synthesis and antibacterial properties. Eur Polym J 45: 779-787.
107. Moehring HD, Gravel C, Chapman MW et al (2000) Comparison of antibiotic beads and intravenous antibiotics in open fractures. Clin Orthop Rel Res 372: 254-261.
108. Mogosanu GD, Grumezescu AM (2014) Natural and synthetic polymers for wounds and burns dressing. Int J Pharm 463: 127-136.
109. Moojen DJ, Vogely HC, Fleer A et al (2009) Prophylaxis of infection and effects on osseointegration using a tobramycin-periapatite coating on titanium implants-an experimental study in the rabbit. J Orthop Res 27: 710-716.
110. Mookherjee N, Hancock RE (2007) Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections. Cell Mol Life Sci 64: 922-933.
111. Moretti EW, Ofstead CL, Kristy RM et al (2005) Impact of central venous catheter type and methods on catheter-related colonization and bacteraemia. J Hosp Infect 61: 139-145.
112. Morgan SD, Rigby D, Stickler DJ (2009) A study of the structure of the crystalline bacterial biofilms that can encrust and block silver Foley catheters. Urol Res 37: 89-93.
113. Munoz-Bonilla A, Fernandez-Garcia M (2012) Polymeric materials with antimicrobial activity. Prog Polym Sci 37: 281-339.
114. Nazarko L (2008) Reducing the risk of catheter-related urinary tract infection. Br J Nurs 17: 1002, 1004, 1006.
115. Neut D, van de Belt H, van Horn JR et al (2003) The effect of mixing on gentamicin release from polymethylmethacrylate bone cements. Acta Orthop Scand 74: 670-676.
116. Neut D, Hendriks JG, van Horn JR et al (2006) Antimicrobial efficacy of gentamicin-loaded acrylic bone cements with fusidic acid or clindamycin added. J Orthop Res 24: 291-299.
117. Neut D, Dijkstra RJ, Thompson JI et al (2011) Antibacterial efficacy of a new gentamicin-coating for cementless prostheses compared to gentamicin-loaded bone cement. J Orthop Res 29: 1654-1661.
118. O'Grady NP, Alexander M, Burns LA et al (2011) Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 52: e162-e193.
119. Osmon DR, Berbari EF, Berendt AR et al (2013) Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 56: e1-e25.
120. Ostendorf T, Meinhold A, Harter C et al (2005) Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients-a doubleblind, randomised, prospective, controlled trial. Support Care Cancer 13: 993-1000.
121. Palermo EF, Kuroda K (2010) Structural determinants of antimicrobial activity in polymers which mimic host defense peptides. Appl Microbiol Biotechnol 87: 1605-1615.
122. Park ES, Kim HK, Shim JH et al (2004a) Synthesis and properties of polymeric biocides based on poly(ethylene-co-vinyl alcohol). J Appl Polym Sci 93: 765-770.
123. Park ES, Kim HS, Kim MN et al (2004b) Antibacterial activities of polystyrene-block-poly(4-vinyl pyridine) and poly(styrene-random-4-vinyl pyridine). Eur Polym J 40: 2819-2822.
124. Pasquier N, Keul H, Heine E et al (2008) Amphiphilic branched polymers as antimicrobial agents. Macromol Biosci 8: 903-915.
125. Percival SL, Hill KE, Williams DW et al (2012) A review of the scientific evidence for biofilms in wounds. Wound Repair Regen 20: 647-657.
126. Pillai CKS, Paul W, Sharma CP (2009) Chitin and chitosan polymers: chemistry, solubility and fiber formation. Prog Polym Sci 34: 641-678.
127. Piozzi A, Francolini I, Occhiaperti L et al (2004) Antimicrobial activity of polyurethanes coated with antibiotics: a new approach to the realization of medical devices exempt from microbial colonization. Int J Pharm 280: 173-183.
128. Raad I, Reitzel R, Jiang Y et al (2008) Anti-adherence activity and antimicrobial durability of anti-infectivecoated catheters against multidrug-resistant bacteria. J Antimicrob Chemother 62: 746-750.
129. Raad I, Mohamed JA, Reitzel RA et al (2012) Improved antibiotic-impregnated catheters with extendedspectrum activity against resistant bacteria and fungi. Antimicrob Agents Chemother 56: 935-941.
130. Ranucci M, Isgro G, Giomarelli PP et al (2003) Impact of oligon central venous catheters on catheter colonization and catheter-related bloodstream infection. Crit Care Med 31: 52-59.
131. Rayman G, Rayman A, Baker NR et al (2005) Sustained silver-releasing dressing in the treatment of diabetic foot ulcers. Br J Nurs 14: 109-114.
132. Ren XH, Kocer HB, Kou L et al (2008) Antimicrobial polyester. J Appl Polym Sci 109: 2756-2761.
133. Rungsardthong U, Deshpande M, Bailey L et al (2001) Copolymers of amine methacrylate with poly(ethylene glycol) as vectors for gene therapy. J Control Release 73: 359-380.
134. Rupp ME, Lisco SJ, Lipsett PA et al (2005) Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med 143: 570-580.
135. Ruszczak Z, Friess W (2003) Collagen as a carrier for onsite delivery of antibacterial drugs. Adv Drug Deliv Rev 55: 1679-1698.
136. Saidin S, Chevallier P, Abdul Kadir MR et al (2013) Polydopamine as an intermediate layer for silver and hydroxyapatite immobilisation on metallic biomaterials surface. Mater Sci Eng C Mater Biol Appl 33: 4715-4724.
137. Saint S, Chenoweth CE (2003) Biofilms and catheterassociated urinary tract infections. Infect Dis Clin North Am 17: 411-432.
138. Saint S, Elmore JG, Sullivan SD et al (1998) The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis. Am J Med 105: 236-241.
139. Sambhy V, Peterson BR, Sen A (2008) Antibacterial and hemolytic activities of pyridinium polymers as a function of the spatial relationship between the positive charge and the pendant alkyl tail. Angewandte Chemie-Int Edition 47: 1250-1254.
140. Sauvet G, Dupond S, Kazmierski K et al (2000) Biocidal polymers active by contact. V. Synthesis of polysiloxanes with biocidal activity. J Appl Polym Sci 75: 1005-1012.
141. Schierholz JM, Rump A, Pulverer G (1997) New antiinfectious biomaterials. Ciprofloxacin containing polyurethanes as potential drug delivery systems to prevent foreign-body infections. Arzneimittelforschung 47: 70-74.
142. Schierholz JM, Fleck C, Beuth J et al (2000) The antimicrobial efficacy of a new central venous catheter with long-term broad-spectrum activity. J Antimicrob Chemother 46: 45-50.
143. Schmidmaier G, Lucke M, Wildemann B et al (2006) Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: a review. Injury 37(Suppl 2): S105-S112.
144. Schmitt MA, Weisblum B, Gellman SH (2004) Unexpected relationships between structure and function in alpha, beta-peptides: antimicrobial foldamers with heterogeneous backbones. J Am Chem Soc 126: 6848-6849.
145. Schumm K, Lam TBL (2008) Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review. NeurourolUrodyn 27: 738-746.
146. Scott CP, Higham PA, Dumbleton JH (1999) Effectiveness of bone cement containing tobramycin. An in vitro susceptibility study of 99 organisms found in infected joint arthroplasty. J Bone Joint Surg Br 81: 440-443.
147. Sellenet PH, Allison B, Applegate BM et al (2007) Synergistic activity of hydrophilic modification in antibiotic polymers. Biomacromolecules 8: 19-23.
148. Sripriya R, Kumar MS, Sehgal PK (2004) Improved collagen bilayer dressing for the controlled release of drugs. J Biomed Mater Res B Appl Biomater 70B: 389-396.
149. Sterling GJ, Crawford S, Potter JH et al (2003) The pharmacokinetics of Simplex-tobramycin bone cement. J Bone Joint Surg Br 85: 646-649.
150. Stickler DJ (2008) Bacterial biofilms in patients with indwelling urinary catheters. Nat Clin Pract Urol 5: 598-608.
151. Stickler DJ (2014) Clinical complications of urinary catheters caused by crystalline biofilms: something needs to be done. J Intern Med 276: 120-129.
152. Stickler DJ, Morgan SD (2008) Observations on the development of the crystalline bacterial biofilms that encrust and block Foley catheters. J Hosp Infect 69: 350-360.
153. Stoiser B, Kofler J, Staudinger T et al (2002) Contamination of central venous catheters in immunocompromised patients: a comparison between two different types of central venous catheters. J Hosp Infect 50: 202-206.
154. Tamaki M, Kokuno M, Sasaki I et al (2009) Syntheses of low-hemolytic antimicrobial gratisin peptides. Bioorg Med Chem Lett 19: 2856-2859.
155. Tan H, Guo S, Yang S et al (2012a) Physical characterization and osteogenic activity of the quaternized chitosan-loaded PMMA bone cement. Acta Biomater 8: 2166-2174.
156. Tan HL, Lin WT, Tang TT (2012b) The use of antimicrobial-impregnated PMMA to manage periprosthetic infections: controversial issues and the latest developments. Int J Artif Organs 35: 832-839.
157. Thakur RA, Florek CA, Kohn J et al (2008) Electrospun nanofibrous polymeric scaffold with targeted drug release profiles for potential application as wound dressing. Int J Pharm 364: 87-93.
158. Tiller JC, Liao CJ, Lewis K et al (2001) Designing surfaces that kill bacteria on contact. Proc Natl Acad Sci U S A 98: 5981-5985.
159. Timofeeva L, Kleshcheva N (2011) Antimicrobial polymers: mechanism of action, factors of activity, and applications. Appl Microbiol Biotechnol 89: 475-492.
160. Ueng SW, Hsieh PH, Shih HN et al (2012) Antibacterial activity of joint fluid in cemented total-knee arthroplasty: an in vivo comparative study of polymethylmethacrylate with and without antibiotic loading. Antimicrob Agents Chemother 56: 5541-5546.
161. van de Wetering P, Schuurmans-Nieuwenbroek NME, van Steenbergen MJ et al (2000) Copolymers of 2-(dimethylamino) ethyl methacrylate with ethoxytriethylene glycol methacrylate or N-vinyl-pyrrolidone as gene transfer agents. J Control Release 64: 193-203.
162. Venkataraman S, Zhang Y, Liu LH et al (2010) Design, syntheses and evaluation of hemocompatible pegylated-antimicrobial polymers with well-controlled molecular structures. Biomaterials 31: 1751-1756.
163. Vester H, Wildemann B, Schmidmaier G et al (2010) Gentamycin delivered from a PDLLA coating of metallic implants: in vivo and in vitro characterisation for local prophylaxis of implant-related osteomyelitis. Injury 41: 1053-1059.
164. Walder B, Pittet D, Tramer MR (2002) Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a metaanalysis. Infect Control Hosp Epidemiol 23: 748-756.
165. Woo GL, Mittelman MW, Santerre JP (2000) Synthesis and characterization of a novel biodegradable antimicrobial polymer. Biomaterials 21: 1235-1246.
166. Woo GL, Yang ML, Yin HQ et al (2002) Biological characterization of a novel biodegradable antimicrobial polymer synthesized with fluoroquinolones. J Biomed Mater Res 59: 35-45.
167. Yasani BR, Martinelli E, Galli G et al (2014) A comparison between different fouling-release elastomer coatings containing surface-active polymers. Biofouling 30: 387-399.
168. Yin HQ, Langford R, Burrell RE (1999) Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J Burn Care Rehabil 20: 195-200.
169. Yucel N, Lefering R, Maegele M et al (2004) Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: a randomized controlled clinical trial. J Antimicrob Chemother 54: 1109-1115.
170. Zainul Abid CKV, Chattopadhyay S, Mazumdar N et al (2010) Synthesis and characterization of quaternary ammonium PEGDA dendritic copolymer networks for water disinfection. J Appl Polym Sci 116: 1640-1649.
171. Zhang H, Sun Y, Tian A et al (2013) Improved antibacterial activity and biocompatibility on vancomycinloaded TiO2 nanotubes: in vivo and in vitro studies. Int J Nanomedicine 8: 4379-4389.